Yonsei University College of Medicine, Severance Hospital

Seoul 3722

2 studies enrolling now · 7 studies all time

What they study most

Crohn's Disease, Diabetic Nephropathy, Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer, Lupus Nephritis (LN), Multiple Myeloma, Psoriasis, Ulcerative Colitis

Studies at this site

• Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis — Recruiting now
• Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma — Recruiting now
• Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer — Completed
• A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis — Completed
• Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease — Completed
• A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis — Stopped early
• A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy — Completed